Article Types
Editorials
The problem with modern endocrinology
Improved doctor–patient communications and more research are necessary
Jeffrey D Zajac
Preventing all the complications of hyperglycaemia: not a straightforward task
Individualised multifactorial treatment strategies are required to optimise outcomes
Aidan McElduff
Improving outcomes in coronary artery disease
Systems, procedures and policies are needed to further reduce the toll of cardiovascular disease
Andrew I MacIsaac
Ensuring access to invasive care for all patients with acute coronary syndromes: beyond our reach?
We need to ensure that those who need care most receive it
Ian A Scott
Relieving the pressure: new Australian hypertension guideline
The National Heart Foundation guideline has been updated to reflect recent evidence and Australian conditions
Garry LR Jennings
Rising costs of hip fractures
Early, intensive intervention may complement fall prevention in reducing the personal and financial costs
Andreas Loefler · Jacqui Close
A new look MJA
On behalf of the entire editorial team, welcome to the new look MJA. Over the past 6 months, we have reviewed every aspect of our editorial process and production, all in an effort to provide you the reader and all prospective authors with the best possible experience that we can. We are excited to debut this new look issue with an Indigenous health theme and are grateful for the input of Guest Editor Professor Shane Houston for his valuable insights in this important field. Your journal is now divided into three distinct sections — blue, red and green. The blue section starts us off and contains important news, perspectives, debates, lessons from practice, clinical snapshots with an image, a new educational series, information on medical law and ethics, historical vignettes, and other articles that are of broad interest to all. For example, in this issue we are proud to launch our new clinical skills series that we hope will be of value not only to doctors in training and medical students but also to experienced clinicians. This year we will also commence a new series in innovations in medical education and a series to demystify research methodology and statistics. The red section follows, led by editorials usually linked to research articles, original research articles, and short research reports. Based on reader and author feedback, we have dispensed with only publishing summaries of research articles in print; instead we will publish research in full in the red section. A new feature included with original research articles will be a summary box highlighting the known, the new and the implications, to help guide readers to studies that they will want to read in detail. We will also publish excellent systematic reviews, meta-analyses, expert reviews and guidelines in the red section, and we strongly encourage their submission for consideration. A fresh letters to the editor section has been reinstated; the online response section has been retained. We are especially interested in letters that provide insights into research that we have published, as this is a key final part of the peer review process. Finally, the green section wraps up the content with careers and miscellaneous material of general interest. We welcome your feedback on the new format and other aspects of the Journal. All articles, including original research, reviews and perspectives, will continue to undergo multiple layers of rigorous review to ensure that we publish the best possible content. Initially, submitted articles are reviewed by an experienced medical editor, who will obtain a second medical editor opinion if needed. If the manuscript passes this stage, formal peer review is obtained and, if relevant, also a statistical review. The manuscript and reviewer comments are then discussed by the entire team of editors including, where applicable, an expert statistician at the manuscript review meeting, held twice weekly. If the manuscript passes this stage, it is returned to the authors for revision. We are working to streamline our processes so authors receive a more rapid decision while always maintaining our high standards. I am very pleased to announce that we have new MJA editorial advisory group (https://www.mja.com.au/journal/staff/mja-editorial-advisory-committee). The members include leading clinicians and academics from multiple fields, and a medical student representative. The advisory group has met with the editorial team twice now, and is providing guidance and input that we deeply value. You will notice that we have included prominent international colleagues from New Zealand, Hong Kong, the United Kingdom and Canada. This is consistent with the Journal’s interest in taking Australia’s best research to the world and bringing such research here for our readers, and expansion of international membership will be considered. Guest editors will also appear in the Journal to contribute to the development of themed issues and the teaching series. As well as doing all we can to look after our readership, we will continue to support our prospective authors in every possible way. We provide as much guidance as we can because we want to improve promising articles. Translation of research into practice is a priority for health and for this reason we will now offer a fast track process for clinical trial manuscripts. We will also streamline the publication of clinical guidelines and consensus statement manuscripts that have already been through a rigorous peer review process. Thank you to everyone who has published in the MJA since my tenure began in December 2015.1 Your work is deeply valued and I remain impressed by the very high quality of submissions we are seeing every day. We can only publish a fraction of what we receive but there are many advantages to publishing in the MJA.2 Along with the MJA being one of the world’s leading general medical journals (ranked among the top 20 globally in 2015), an obvious advantage is that there is no cost to authors but every original research article is immediately made available in full for free. This means that clinicians, policy makers and researchers can read and cite your work as soon as it is published. We believe important research should be widely accessible, with no barriers. By making your research available in this fashion, we are doing our part to support the advancement of medicine here and around the world. Please refer to the updated author guidelines on our website for all the information needed for submission (https://www.mja.com.au/journal/mja-instructions-authors). I would like to personally thank all our authors and readers, peer reviewers, new members of the editorial advisory group, and my team for your contributions to the MJA. Your support ensures that the proud tradition of the MJA continues.
Nicholas J Talley
We need transformative change in Aboriginal health
Overcoming the soft bigotry of low expectations
Shane Houston
Access to contraception for remote Aboriginal and Torres Strait Islander women: necessary but not sufficient
Comprehensive sexual and reproductive health care contributes to the autonomy of Indigenous women
Sarah L Larkins · Priscilla Page
Carers of Indigenous children: services and systems failure? Where to next?
We need to find solutions that adequately engage Indigenous carers in mental health care
Beth Mah · Kym M Rae
Financial toxicity in clinical care today: a “menu without prices”1
Out-of-pocket costs are rising rapidly and can influence treatment decisions and health outcomes
David Currow PhD, FRACP, FAHMS · Sanchia Aranda PhD, MN, BAppSci
Changing eating patterns versus adding nutrients to processed foods
Food-based dietary guidelines are necessary but the processed food industry prefers to concentrate on individual nutrients
Rosemary A Stanton BSc, GradDipAdmin, PhD(Hon)
Strengthening primary health care to improve Indigenous health outcomes
We need better, more culturally sensitive models for delivering primary care
John Wakerman MTH, FAFPHM, FACRRM · Cindy Shannon BA, MBA, DSocSci
To screen for depression or not?
Screening may be appropriate to reconsider once we can ensure adequate response to any identified potential cases
Malcolm J Hopwood MB BS, MD, FRANZCP · Gin Malhi FRCPsych, MD, FRANZCP
How can we ensure that people with lung cancer living in rural and remote areas are treated surgically when appropriate?
We have the will to improve cancer services for patients outside major cities but, thus far, not the way
Elizabeth Tracey BSc(Hons), MPH, PhD · Brian C McCaughan MB BS, FRACS · Jane M Young MPH, PhD, FAFPHM · Bruce K Armstrong MB BS(Hons), DPhil, FRACP
E-cigarettes should be regulated
They pose many risks for tobacco control and health, and any possible benefits are few and uncertain
Martin McKee MD, DSc · Mike Daube BA(Hons), HonDSci · Simon Chapman PhD, FASSA, HonFFPH
The role of neurosurgery in the treatment of chronic pain
Neurosurgical training should formally incorporate chronic pain management
Peter J Teddy DPhil, FRACS, FFPMANZCA
Futility and utility
The physician should focus on what can be done, not on what cannot
Ian Maddocks MD, FRACP, FAChPM
Improving quality in prostate cancer
Quality indicators can provide reassurance that cancer care is achieving the predicted outcomes
Paul S Craft MB BS, FRACP, MPH
Lost in translation: the gap between what we know and what we do about cardiovascular disease
A million Australians at high risk may not be receiving recommended preventive treatments
Clara K Chow MB BS, FRACP, PhD · Anthony Rodgers MB ChB, PhD
Creating health care value together: a means to an important end
Using a value co-creation approach to build closer integration between researchers and the “business” of health care can deliver effective health care reform
Claire L Jackson MB BS, MD, MPH · Tina Janamian PhD, MBA, MMedSc · Mark Booth EMPA, MEcon · Diane Watson PhD
Value co-creation driving Australian primary care reform
Harnessing our collective capability could enable effective, ongoing reform
Claire L Jackson MB BS, MD, MPH · Steven J Hambleton MB BS, FAMA
Zika preparedness in Australia
Our comprehensive national response encompasses prevention and surveillance, as well as monitoring and controlling Aedes aegypti in Australia
Chris Baggoley FACEM, BM BS, BVSc · Katrina Knope BSc, MPH · Anna Colwell MB BS(Hon), FRACGP, MPH · Jenny Firman MB BS, FRACGP
The ASID test
The Australasian Society for Infectious Diseases view on infectious diseases challenges in 2016 and beyond
Cheryl A Jones MB BS(Hon), PhD, FRACP · Joshua S Davis MB BS, DTM · David FM Looke FRACP, FRCPA, MMedSci(ClinEpid)
Multidrug-resistant tuberculosis in Australia and our region
MDR-TB threatens TB control programs in Australia’s region and will not diminish without concerted efforts
James M Trauer MPH, FRACP, FAFPHM · Allen C Cheng MPH, PhD, FRACP